We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Fundus Autofluorescence Is Not the Best Early Screen for Hydroxychloroquine Toxicity—Reply

Ian R. Gorovoy, MD1; Mark S. Gorovoy, MD2
[+] Author Affiliations
1Department of Ophthalmology, University of California, San Francisco
2Gorovoy Eye Specialists, Fort Myers, Florida
JAMA Ophthalmol. 2013;131(11):1488. doi:10.1001/jamaophthalmol.2013.5077.
Text Size: A A A
Published online


In Reply We agree fully with the comments from Dr Marmor, whom we consider the leading authority regarding hydroxychloroquine maculopathy. A bull’s-eye should never be seen if patients are well screened, as it signifies advanced disease.

These images were intended to remind ophthalmologists that hydroxychloroquine maculopathy still exists, especially when patients have been poorly followed up or overdosed. In preventive medicine, however, the question of discontinuation of hydroxychloroquine often places the health care practitioner who is screening for soft signs of early toxic effects in the difficult position of discontinuing an excellent and systemically safe drug vs risking irreversible vision loss from toxicity. Confirmatory tests such as autofluorescence and multifocal electroretinography may facilitate the decision on whether to observe or stop the medication.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





November 1, 2013
Michael F. Marmor, MD
1Byers Eye Institute at Stanford, Palo Alto, California
JAMA Ophthalmol. 2013;131(11):1487-1488. doi:10.1001/jamaophthalmol.2013.4835.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...